Purchase Order N0018925PZ542
Award Date 9/23/25
Potential Completion Date 9/22/26
Potential Value $247K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Philippines
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Navy's Bureau of Medicine and Surgery awarded a $247,866 firm fixed-price purchase order to Pathoseq Bio, LLC on July 1, 2024, for medical research and development services. This contract, set aside for total small business participation, is scheduled for completion by September 30, 2025, and will be performed in the United States Minor Outlying Islands. The award resulted from Solicitation AN42, issued by Naval Supply Systems Command, which sought health research and...
- This federal contract award was made by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Pathoseq Bio, LLC, a small business limited liability company. The $155,106.15 firm-fixed-price contract is for genomic analysis services, with a period of performance through March 31, 2025. The contract was set aside for total small business participation. Pathoseq Bio specializes in advanced biological research, genomic analysis, and biothreat detection for federal...
- The U.S. Navy Bureau of Medicine and Surgery awarded a $147,788.96 firm fixed-price purchase order to Biosurv International LTD for the development of bioinformatics protocols capable of agnostic detection of bacterial versus viral diseases. The contract was awarded on September 4, 2025, with an ultimate completion date of September 28, 2026. The work will be performed in New Guinea. No set-aside designation was applied to this procurement. This contract supports the Department of Defense's...
- The U.S. Department of the Navy awarded a $247,371.53 firm-fixed-price purchase order contract to Praesensbio LLC, a for-profit limited liability company, for a "Sequence Based Detection Biothreat Agent" requirement. The contract has a period of performance through March 29, 2024 and was awarded on September 27, 2023 without a set-aside. The requirement was originally solicited as an 8(a) sole source opportunity. Based on the description, this contract appears to support the Department...
- <p>The Department of the Navy Bureau of Medicine and Surgery awarded a $248,637.36 firm-fixed-price purchase order to Praesensbio LLC, a for-profit limited liability company, for sequence-based characterization of SARS. The contract has a performance period ending on September 26, 2023 and was awarded on September 26, 2022. The place of performance is Vietnam. No set-aside was used for this award.</p>
- The Naval Medical Research Unit (NAMRU) South, operating under the Bureau of Medicine and Surgery within the Department of Defense, awarded a $60,774.07 purchase order to Illumina, Inc. on September 2, 2025, for the procurement of reagents supporting next-generation sequencing (NGS) projects at the command's centralized laboratory department. The contract utilizes firm fixed-price pricing with no set-aside designation, reflecting Illumina's specialized technological capabilities in genomic...
- The U.S. Navy's Bureau of Medicine and Surgery (BUMED) awarded a $19,131.44 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for laboratory reagents. The contract, awarded on August 28, 2025, will be performed in Peru with an ultimate completion date of September 21, 2026. This award carries no set-aside designation, reflecting the contractor's competitive standing in federal scientific procurement. Life Technologies Corporation is a...
- The U.S. Navy Bureau of Medicine and Surgery (BUMED) awarded a $29,836.50 firm-fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to provide laboratory supplies for the NAMRU-6 research facility in Carlsbad, California. This award does not utilize any set-aside designations. Life Technologies Corporation has a history of serving as a prime contractor across various federal agencies, including the Departments of Defense, Health and Human...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $292,354.46 firm fixed price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of two v2.0 multiplex polymerase chain reaction (PCR) systems, two hard-sided cases, and supporting supplies for the Naval Medical Research Unit No. 6 (NAMRU-6) in Lima, Peru. This procurement was a sole source requirement and did...
- This is a $650,000.00 Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of the Navy, Bureau of Medicine and Surgery (BUMED) to Gen-Probe Incorporated, a medical diagnostics company specializing in molecular testing systems and assays. The contract is for medical pathology services, including the provision of APTIMA assay test kits for detecting infectious diseases such as HIV, chlamydia, gonorrhea, and COVID-19, as well as PANTHER and PANTHER FUSION automated molecular...